A method of diagnosing an asthma subtype in a patient is provided, the method comprising measuring the gene expression of POSTN, CST1, CST2 and/or SERPINB10, wherein elevated expression levels of said genes or respective proteins are indicative of the asthma subtype. Also provided are uses, diagnostic kits and agents for use in a method for treatment of asthma.